Clinical Trial Update: Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating repeated intravenous thrombolysis with prourokinase for acute ischemic stroke due to medium-to-large vessel occlusion presen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• ProUrokinase (pro-urokinase)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Acute Ischemic Stroke | Phase 2 | Status: NOT_YET_RECRUITING